Unichem Laboratories logo

Unichem Laboratories results

NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap

Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.

52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
Market cap
₹3,330 Cr1,036th largest listed
P/E
10.9
P/E without one-offs
33.3
P/B
1.2
Dividend yield
Nonein the last 12 months
ROE
11.8%
ROE without one-offs
3.9%
ROCE
3.3%
Debt to equity
0.17
Volume, NSE
40,08440.7% delivered

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Unichem Laboratories annual results and balance sheet

Revenue
₹633 Cr+20.1% on a year ago · +10.0% on the quarter before
Operating profit
₹70 Cr+211.0% on a year ago · +46.7% on the quarter before
Net profit
₹41 Cr+280.1% on the quarter before
Operating margin
11.1%
Net margin
6.6%

From revenue to net profit, ₹ crore

  1. Revenue633
  2. Materials and goods−289
  3. Employee costs−103
  4. Other expenses−171
  5. Operating profit70
  6. Depreciation−30
  7. Other income+16
  8. Finance costs−6.6
  9. Profit before tax49
  10. Tax−7.5
  11. Net profit41

Unichem Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 3 NovDec 2021Q3Filed 29 JanMar 2022Q4Filed 27 MayJun 2022Q1Filed 10 AugSep 2022Q2Filed 12 NovDec 2022Q3Filed 7 FebMar 2023Q4Filed 23 MayJun 2023Q1Filed 14 JulSep 2023Q2Filed 2 NovDec 2023Q3Filed 5 FebMar 2024Q4Filed 23 MayJun 2024Q1Filed 20 AugSep 2024Q2Filed 13 NovDec 2024Q3Filed 6 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 4 AugSep 2025Q2Filed 11 NovDec 2025Q3Filed 5 FebMar 2026Q4Filed 22 MayJun 2026Q1Filed 11 Aug
Revenue from operations291311370310329302402423416434432446462533587527579521575633
284312302311347345386395407396406403405448503504513476527563
Materials and goods bought9810998110130138173168163166167161174192265245270237268289
Employee costs81828688899189999798999899102961071009993103
Other expenses105120118113128117124128147132140144131154142152142140167171
Operating profit before depreciation7−168−1−18−43162893825435886842266454870
Operating margin2.3%−0.2%18.5%−0.3%−5.6%−14.1%4.1%6.6%2.1%8.8%5.9%9.7%12.4%16.0%14.3%4.3%11.4%8.6%8.3%11.1%
Depreciation and amortisation2223232528313029292827282931303231313130
Other income31514891659611649149721122316
Finance costs21235466765457578797
Profit before one-off items and tax−15−1158−21−42−61−142−2216015336258−947183149
One-off items0000−50−340068−12600000−58276−120
Profit before tax−15−1158−21−47−61−472−2284−12615336258−9−112931949
−33−143233−333036345112988
Tax rate––−23.4%––––131.6%–0.0%–38.3%7.6%6.5%8.4%––9.9%41.9%15.4%
Share of profit of joint ventures and associates0−1––––––––––––––––––
Net profit−13−1471−23−71−64−44−1−2484−1299305853−10−122641141
Other comprehensive income−3−2597410−3−3−1−2−10−32−632−29−3
Total comprehensive income−16−16130−17−29−64−47−3−2582−13010286047−7−102622038
Net margin−4.4%−4.5%19.3%−7.5%−21.5%−21.1%−11.0%−0.2%−5.9%19.3%−30.0%2.1%6.6%10.9%9.0%−2.0%−2.1%50.7%1.9%6.6%
Net margin without joint ventures and associates−4.3%−4.3%––––––––––––––––––
Earnings per share−₹1.82−₹2.01₹10.15−₹3.32−₹10.04−₹9.08−₹6.28−₹0.09–₹11.93−₹18.37₹1.31₹4.34₹8.22₹7.52−₹1.49−₹1.69₹37.54₹1.55–
Diluted earnings per share−₹1.82−₹2.01₹10.14−₹3.32−₹10.04−₹9.08−₹6.28−₹0.09–₹11.92−₹18.36₹1.31₹4.32₹8.19₹7.50−₹1.49−₹1.69₹37.47₹1.55–
Earnings per share in rupees, restated for later splits and bonuses.

The quarters either side of a change of basis do not compare. From the quarter to Mar 2025, the company's revenue for the year to Mar 2025, ₹2,111 Cr, differs from its quarters added, ₹2,029 Cr.

Filed results, as an XML file each

16 earlier filings